20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

News

BioGenerator News

BioGenerator Company MediBeacon Granted FDA Breakthrough Status

Oct 22, 2018

MediBeacon’s Breakthrough Device is Intended to Measure GFR in Patients with Impaired or Normal Kidney Function ST. LOUIS, Oct. 22, 2018 /PRNewswire/ — MediBeacon Inc., whose largest shareholder is Pansend Life […]

Read More

BioGenerator Company Cardialen Closes $17 Million Series B Financing for Heart Rhythm Therapy

Oct 10, 2018

CARDIALEN IS DEVELOPING A LOW-ENERGY IMPLANTABLE DEFIBRILLATION THERAPY DESIGNED TO MORE GENTLY RESTORE THE HEART TO A NORMAL RHYTHM. Minneapolis, Oct. 10, 2018 – Cardialen, Inc., a medical device company […]

Read More

BioGenerator Company Galera Therapeutics Raises $150 Million to Advance Breakthrough Therapy

Sep 19, 2018

Largest Series C venture round raised by a St. Louis bioscience company Galera Therapeutics, Inc., a clinical-stage drug discovery company, whose research and development is based in St. Louis, today […]

Read More

BioGenerator Company Benson Hill Biosystems Raises $60 Million Series C led by GV

Sep 10, 2018

BioGenerator portfolio company Benson Hill Biosystems, a crop improvement company unlocking the natural genetic diversity of plants, today announced the first close of its $60 million Series C financing.  BioGenerator was […]

Read More

BioGenerator Company BlueStrata EHR Acquired by Mediware

Aug 01, 2018

BioAcquisition expands Mediware’s solutions to include software for skilled nursing and assisted living facilities and offers BlueStrata EHR expanded resources for investments in innovation and sales. Mediware Information Systems, Inc., […]

Read More

$100 million Confluence deal is good exit for BioGenerator

May 24, 2018

Following Pfizer’s announcement to cut 600 of its 1,000 St. Louis-area jobs in 2009, several Pfizer executives, including Joe Monahan and Walter Smith, faced a difficult decision. They could relocate […]

Read More

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Venture Capital Financing for Canopy Biosciences

May 22, 2018

Startup to Advance Research Tools Development and Add Jobs ST. LOUIS – Canopy Biosciences has exceeded its Series A financing goal, closing a $2.4 million investment to develop new research […]

Read More

BacterioScan, a BioGenerator portfolio company, secures FDA clearance – UTI detection in hours, not days

May 14, 2018

St. Louis, May 14, 2018 – BacterioScan, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a 510(k) Premarket Notification clearance for its 216Dx Urinary Tract […]

Read More

BioGenerator Company RNAgri Inks Deal with Monsanto for Use of RNA Production Technology

Apr 04, 2018

BioGenerator-backed AgTech Company Focuses on Naturally-Occurring Process ST. LOUIS – RNAgri, a St. Louis startup developing technology for agriculture, has entered a research collaboration with global agriculture company Monsanto. The […]

Read More

St. Louis-based Unleash Immuno Oncolytics Attracts $3 Million Investment from Publicly-traded Japanese Company

Feb 19, 2018

BioGenerator-supported Company to Advance Cancer Therapies ST. LOUIS – St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors